BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23748116)

  • 1. Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation.
    Silos-Santiago I; Hannig G; Eutamene H; Ustinova EE; Bernier SG; Ge P; Graul C; Jacobson S; Jin H; Liong E; Kessler MM; Reza T; Rivers S; Shea C; Tchernychev B; Bryant AP; Kurtz CB; Bueno L; Pezzone MA; Currie MG
    Pain; 2013 Sep; 154(9):1820-1830. PubMed ID: 23748116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
    Castro J; Harrington AM; Hughes PA; Martin CM; Ge P; Shea CM; Jin H; Jacobson S; Hannig G; Mann E; Cohen MB; MacDougall JE; Lavins BJ; Kurtz CB; Silos-Santiago I; Johnston JM; Currie MG; Blackshaw LA; Brierley SM
    Gastroenterology; 2013 Dec; 145(6):1334-46.e1-11. PubMed ID: 23958540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity
    Boulete IM; Thadi A; Beaufrand C; Patwa V; Joshi A; Foss JA; Eddy EP; Eutamene H; Palejwala VA; Theodorou V; Shailubhai K
    World J Gastroenterol; 2018 May; 24(17):1888-1900. PubMed ID: 29740204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRP4 Modulation of the Guanylate Cyclase-C/cGMP Pathway: Effects on Linaclotide-Induced Electrolyte Secretion and cGMP Efflux.
    Tchernychev B; Ge P; Kessler MM; Solinga RM; Wachtel D; Tobin JV; Thomas SR; Lunte CE; Fretzen A; Hannig G; Bryant AP; Kurtz CB; Currie MG; Silos-Santiago I
    J Pharmacol Exp Ther; 2015 Oct; 355(1):48-56. PubMed ID: 26216942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.
    Eutamene H; Bradesi S; Larauche M; Theodorou V; Beaufrand C; Ohning G; Fioramonti J; Cohen M; Bryant AP; Kurtz C; Currie MG; Mayer EA; Bueno L
    Neurogastroenterol Motil; 2010 Mar; 22(3):312-e84. PubMed ID: 19706070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C.
    Sindić A; Velic A; Başoglu C; Hirsch JR; Edemir B; Kuhn M; Schlatter E
    Kidney Int; 2005 Sep; 68(3):1008-17. PubMed ID: 16105031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanylin peptides: cyclic GMP signaling mechanisms.
    Forte LR; Freeman RH; Krause WJ; London RM
    Braz J Med Biol Res; 1999 Nov; 32(11):1329-36. PubMed ID: 10559833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of uroguanylin and guanylin in vivo.
    Carrithers SL; Hill MJ; Johnson BR; O'Hara SM; Jackson BA; Ott CE; Lorenz J; Mann EA; Giannella RA; Forte LR; Greenberg RN
    Braz J Med Biol Res; 1999 Nov; 32(11):1337-44. PubMed ID: 10559834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylate Cyclase C: A Current Hot Target, from Physiology to Pathology.
    Uranga JA; Castro M; Abalo R
    Curr Med Chem; 2018; 25(16):1879-1908. PubMed ID: 29210639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanylin, uroguanylin, and heat-stable euterotoxin activate guanylate cyclase C and/or a pertussis toxin-sensitive G protein in human proximal tubule cells.
    Sindiće A; Başoglu C; Cerçi A; Hirsch JR; Potthast R; Kuhn M; Ghanekar Y; Visweswariah SS; Schlatter E
    J Biol Chem; 2002 May; 277(20):17758-64. PubMed ID: 11889121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanylate cyclase-C/cGMP: an emerging pathway in the regulation of visceral pain.
    Hannig G; Tchernychev B; Kurtz CB; Bryant AP; Currie MG; Silos-Santiago I
    Front Mol Neurosci; 2014; 7():31. PubMed ID: 24795564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology.
    Forte LR
    Regul Pept; 1999 May; 81(1-3):25-39. PubMed ID: 10395405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
    Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR
    Cancer Res; 2000 Sep; 60(18):5151-7. PubMed ID: 11016642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction pathways via guanylin and uroguanylin in stomach and intestine.
    London RM; Krause WJ; Fan X; Eber SL; Forte LR
    Am J Physiol; 1997 Jul; 273(1 Pt 1):G93-105. PubMed ID: 9252514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine.
    Ahsan MK; Tchernychev B; Kessler MM; Solinga RM; Arthur D; Linde CI; Silos-Santiago I; Hannig G; Ameen NA
    Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28592587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opossum colonic mucosa contains uroguanylin and guanylin peptides.
    Hamra FK; Krause WJ; Eber SL; Freeman RH; Smith CE; Currie MG; Forte LR
    Am J Physiol; 1996 Apr; 270(4 Pt 1):G708-16. PubMed ID: 8928802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity.
    Hamra FK; Eber SL; Chin DT; Currie MG; Forte LR
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2705-10. PubMed ID: 9122260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanylin peptides: renal actions mediated by cyclic GMP.
    Forte LR; London RM; Freeman RH; Krause WJ
    Am J Physiol Renal Physiol; 2000 Feb; 278(2):F180-91. PubMed ID: 10662722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated H2 O2 levels in trinitrobenzene sulfate-induced colitis rats contributes to visceral hyperalgesia through interaction with the transient receptor potential ankyrin 1 cation channel.
    Kogure Y; Wang S; Tanaka K; Hao Y; Yamamoto S; Nishiyama N; Noguchi K; Dai Y
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1147-53. PubMed ID: 26574143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit.
    Busby RW; Bryant AP; Bartolini WP; Cordero EA; Hannig G; Kessler MM; Mahajan-Miklos S; Pierce CM; Solinga RM; Sun LJ; Tobin JV; Kurtz CB; Currie MG
    Eur J Pharmacol; 2010 Dec; 649(1-3):328-35. PubMed ID: 20863829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.